Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ephedra-containing "street drug alternatives" from four marketers draw warning letters.

This article was originally published in The Tan Sheet

Executive Summary

HERBAL ECSTACY CONTINUED MARKETING FOR "ABUSE AND MISUSE PURPOSES" is illegal, FDA cautions Venice, Calif.-based Global World Media, marketer of the ephedra-containing "street drug alternative," in an Aug. 29 warning letter. "The claims and name" of the product "indicate that `herbal ecstacy' is offered for abuse and misuse purposes," the agency says. "As such, there is no legitimate drug use for this product and its continued marketing is illegal." The product is "misbranded" as well, FDA says, because its labeling "fails to bear adequate directions for the uses" for which it is promoted.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087598

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel